Literature DB >> 2867690

Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia.

O M Wolkowitz, D Pickar, A R Doran, A Breier, J Tarell, S M Paul.   

Abstract

Alprazolam, when added under double-blind conditions to a stable neuroleptic regimen in two patients with schizophrenia, resulted in clinically apparent improvement in positive and negative schizophrenic symptoms. Both patients showed significant worsening of symptoms following reduction or discontinuation of alprazolam.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2867690     DOI: 10.1176/ajp.143.1.85

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  8 in total

1.  Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses.

Authors:  Hadar Zaman; Roger Carl Gibson; Geoffrey Walcott
Journal:  Cochrane Database Syst Rev       Date:  2019-08-05

Review 2.  Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs.

Authors:  M V Rudorfer; W Z Potter
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

3.  Benzodiazepines in psychotic States.

Authors:  J Ananth; O Solano
Journal:  Indian J Psychiatry       Date:  1993-04       Impact factor: 1.759

Review 4.  Benzodiazepines for schizophrenia.

Authors:  Markus Dold; Chunbo Li; Magdolna Tardy; Vesal Khorsand; Donna Gillies; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

5.  Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia.

Authors:  J C Pecknold
Journal:  J Psychiatry Neurosci       Date:  1993-03       Impact factor: 6.186

Review 6.  Depression in schizophrenia: current guidelines to treatment.

Authors:  S J Bartels; R E Drake
Journal:  Psychiatr Q       Date:  1989

Review 7.  Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia.

Authors:  H J Möller; H M van Praag; B Aufdembrinke; P Bailey; T R Barnes; J Beck; H Bentsen; F X Eich; L Farrow; W W Fleischhacker
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

8.  Treatment of the special patient with schizophrenia.

Authors:  R R Conley; D L Kelly
Journal:  Dialogues Clin Neurosci       Date:  2001-06       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.